NCT02391181
Bioequivalence Study With Pharmacokinetic Endpoints, Comparing a Single Dose of Iron Sucrose Azad Injection of Azad Pharma Corporation (AG), With a Single Dose of Venofer® Injection of Vifor Corporation (AG) in Healthy Adult Volunteers
Phase: Phase 1
Role: Lead Sponsor
Start: Nov 30, 2014
Completion: Aug 31, 2015